Login / Signup

Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety.

Paola PonzaniCesare BerraAlessandra Di LelioPaola Del SindacoChiara Di LoretoFrancesco ReggianiGiuseppe LucisanoMaria Chiara Rossi
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Novo Nordisk S.p.A. unconditional grant.
Keyphrases
  • type diabetes
  • electronic health record
  • big data
  • glycemic control
  • machine learning
  • skeletal muscle
  • adipose tissue
  • insulin resistance